Global Metabotropic Glutamate Receptor 2 Market Growth 2026-2032
The global Metabotropic Glutamate Receptor 2 market size is predicted to grow from US$ 8.12 million in 2025 to US$ 12.66 million in 2032; it is expected to grow at a CAGR of 6.4% from 2026 to 2032.
Metabotropic Glutamate Receptor 2 is a central nervous system membrane receptor encoded by the corresponding human gene and belongs to class C G protein-coupled receptors and group II metabotropic glutamate receptors. It is not a single ready-to-use industrial product, but a protein target and related reagent system used in neuroscience, drug discovery, and analytical research. Commercial forms mainly include liquid or lyophilized antibodies, immunoassay kits, expression plasmids, viral vectors, cell models, receptor-modulating small molecules, and functional screening services. Structurally, the receptor is a seven-transmembrane protein with a large extracellular ligand-binding domain, a transmembrane signaling region, and an intracellular coupling region. Its mechanism is to recognize glutamate and transmit signals through inhibitory G proteins, reducing adenylate cyclase activity and regulating presynaptic glutamate release and neural circuit excitability. Technical requirements focus on target sequence accuracy, epitope design, antibody specificity, recombinant expression stability, purity, lot-to-lot consistency, cell-based functional validation, and cold-chain storage.
The market opportunity comes from rising investment in neuroscience, unmet needs in central nervous system disorders, and the druggability of receptor-based targets. As structural biology, recombinant antibody technology, cell-based functional screening, and high-throughput drug discovery improve, related products are shifting from standard research consumables to highly specific, well-validated, and function-oriented product bundles. Depression, schizophrenia, addiction, pain, and viral neuroinvasion research still require new mechanistic explanations and drug candidates, supporting long-term demand for this target in research tools and preclinical discovery.
The main challenge is high uncertainty in clinical translation. This receptor is closely connected with neighboring receptor subtypes, other neurotransmitter pathways, and brain-region-specific signaling, so simple activation, inhibition, or allosteric modulation does not necessarily translate into consistent clinical efficacy. Several historical candidates in psychiatric disorders and epilepsy were discontinued or failed to meet expectations, making large-scale investment more cautious. On the reagent side, suppliers still face antibody cross-reactivity, lot variability, insufficient validation across sample types, and limited sales volume for a niche target.
Downstream demand will move from basic detection toward high-quality validation, functional screening, and integrated services. Universities, hospital laboratories, and pharmaceutical companies will continue to purchase antibodies, assay kits, tool compounds, and cell models, but customers increasingly require specificity validation, cross-species compatibility, stable membrane protein expression, and reproducible data. Future growth is more likely to come from screening platforms, contract research services, recombinant monoclonal replacement of traditional polyclonal antibodies, localization of research reagents, and bundled products for multi-target neural circuit studies rather than large-scale expansion of any single product.
LP Information, Inc. (LPI) ' newest research report, the ?Metabotropic Glutamate Receptor 2 Industry Forecast? looks at past sales and reviews total world Metabotropic Glutamate Receptor 2 sales in 2025, providing a comprehensive analysis by region and market sector of projected Metabotropic Glutamate Receptor 2 sales for 2026 through 2032. With Metabotropic Glutamate Receptor 2 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Metabotropic Glutamate Receptor 2 industry.
This Insight Report provides a comprehensive analysis of the global Metabotropic Glutamate Receptor 2 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Metabotropic Glutamate Receptor 2 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Metabotropic Glutamate Receptor 2 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Metabotropic Glutamate Receptor 2 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Metabotropic Glutamate Receptor 2.
This report presents a comprehensive overview, market shares, and growth opportunities of Metabotropic Glutamate Receptor 2 market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Metabotropic Glutamate Receptor 2 market?
What factors are driving Metabotropic Glutamate Receptor 2 market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Metabotropic Glutamate Receptor 2 market opportunities vary by end market size?
How does Metabotropic Glutamate Receptor 2 break out by Type, by Application?
Metabotropic Glutamate Receptor 2 is a central nervous system membrane receptor encoded by the corresponding human gene and belongs to class C G protein-coupled receptors and group II metabotropic glutamate receptors. It is not a single ready-to-use industrial product, but a protein target and related reagent system used in neuroscience, drug discovery, and analytical research. Commercial forms mainly include liquid or lyophilized antibodies, immunoassay kits, expression plasmids, viral vectors, cell models, receptor-modulating small molecules, and functional screening services. Structurally, the receptor is a seven-transmembrane protein with a large extracellular ligand-binding domain, a transmembrane signaling region, and an intracellular coupling region. Its mechanism is to recognize glutamate and transmit signals through inhibitory G proteins, reducing adenylate cyclase activity and regulating presynaptic glutamate release and neural circuit excitability. Technical requirements focus on target sequence accuracy, epitope design, antibody specificity, recombinant expression stability, purity, lot-to-lot consistency, cell-based functional validation, and cold-chain storage.
The market opportunity comes from rising investment in neuroscience, unmet needs in central nervous system disorders, and the druggability of receptor-based targets. As structural biology, recombinant antibody technology, cell-based functional screening, and high-throughput drug discovery improve, related products are shifting from standard research consumables to highly specific, well-validated, and function-oriented product bundles. Depression, schizophrenia, addiction, pain, and viral neuroinvasion research still require new mechanistic explanations and drug candidates, supporting long-term demand for this target in research tools and preclinical discovery.
The main challenge is high uncertainty in clinical translation. This receptor is closely connected with neighboring receptor subtypes, other neurotransmitter pathways, and brain-region-specific signaling, so simple activation, inhibition, or allosteric modulation does not necessarily translate into consistent clinical efficacy. Several historical candidates in psychiatric disorders and epilepsy were discontinued or failed to meet expectations, making large-scale investment more cautious. On the reagent side, suppliers still face antibody cross-reactivity, lot variability, insufficient validation across sample types, and limited sales volume for a niche target.
Downstream demand will move from basic detection toward high-quality validation, functional screening, and integrated services. Universities, hospital laboratories, and pharmaceutical companies will continue to purchase antibodies, assay kits, tool compounds, and cell models, but customers increasingly require specificity validation, cross-species compatibility, stable membrane protein expression, and reproducible data. Future growth is more likely to come from screening platforms, contract research services, recombinant monoclonal replacement of traditional polyclonal antibodies, localization of research reagents, and bundled products for multi-target neural circuit studies rather than large-scale expansion of any single product.
LP Information, Inc. (LPI) ' newest research report, the ?Metabotropic Glutamate Receptor 2 Industry Forecast? looks at past sales and reviews total world Metabotropic Glutamate Receptor 2 sales in 2025, providing a comprehensive analysis by region and market sector of projected Metabotropic Glutamate Receptor 2 sales for 2026 through 2032. With Metabotropic Glutamate Receptor 2 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Metabotropic Glutamate Receptor 2 industry.
This Insight Report provides a comprehensive analysis of the global Metabotropic Glutamate Receptor 2 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Metabotropic Glutamate Receptor 2 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Metabotropic Glutamate Receptor 2 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Metabotropic Glutamate Receptor 2 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Metabotropic Glutamate Receptor 2.
This report presents a comprehensive overview, market shares, and growth opportunities of Metabotropic Glutamate Receptor 2 market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- LY-487379
- JNJ-40411813
- ADX71149
- Others
- Protein-based Reagents
- Cell-based Products
- Synthetic Chemical Products
- Positive Allosteric Modulators
- Negative Allosteric Modulators
- Non-modulating Detection Reagents
- Polyclonal Antibodies
- Hybridoma Monoclonal Antibodies
- Recombinant Monoclonal Antibodies
- Anxiety Disorders
- Depression
- Schizophrenia
- Chronic Pain
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Thermo Fisher Scientific
- Merck KGaA
- Danaher
- Bio-Techne
- Cell Signaling Technology
- Proteintech
- OriGene Technologies
- GeneTex
- Santa Cruz Biotechnology
- Cayman Chemical
- MedChemExpress
- Selleck Chemicals
- TargetMol
- ApexBio
- GLPBIO
- Adooq Bioscience
- MedKoo Biosciences
- MyBioSource
- Aviva Systems Biology
- Signalway Antibody
- NSJ Bioreagents
- Antibodies Incorporated
- Biorbyt
- Abbexa
- AMSBIO
- Tocris Bioscience
- Hello Bio
- Axon Medchem
- Alomone Labs?IL?
- FUJIFILM Wako Pure Chemical
- Sumitomo Pharma
- Boehringer Ingelheim
- AstraZeneca
- Denovo Biopharma
- Addex Therapeutics
- Noema Pharma
- BOC Sciences
- CUSABIO
- HUABIO
- Abbkine
- FineTest
- Bioss Antibodies
What is the 10-year outlook for the global Metabotropic Glutamate Receptor 2 market?
What factors are driving Metabotropic Glutamate Receptor 2 market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Metabotropic Glutamate Receptor 2 market opportunities vary by end market size?
How does Metabotropic Glutamate Receptor 2 break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Metabotropic Glutamate Receptor 2 Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Metabotropic Glutamate Receptor 2 by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Metabotropic Glutamate Receptor 2 by Country/Region, 2021, 2025 & 2032
2.2 Metabotropic Glutamate Receptor 2 Segment by Type
2.2.1 LY-487379
2.2.2 JNJ-40411813
2.2.3 ADX71149
2.2.4 Others
2.2.5 Metabotropic Glutamate Receptor 2 Sales by Type
2.2.5.1 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2021-2026)
2.2.5.2 Global Metabotropic Glutamate Receptor 2 Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Metabotropic Glutamate Receptor 2 Sale Price by Type (2021-2026)
2.3 Metabotropic Glutamate Receptor 2 Segment by Biological Material Type
2.3.1 Protein-based Reagents
2.3.2 Cell-based Products
2.3.3 Synthetic Chemical Products
2.3.4 Metabotropic Glutamate Receptor 2 Sales by Biological Material Type
2.3.4.1 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Biological Material Type (2021-2026)
2.3.4.2 Global Metabotropic Glutamate Receptor 2 Revenue and Market Share by Biological Material Type (2021-2026)
2.3.4.3 Global Metabotropic Glutamate Receptor 2 Sale Price by Biological Material Type (2021-2026)
2.4 Metabotropic Glutamate Receptor 2 Segment by Receptor Pharmacological Action
2.4.1 Positive Allosteric Modulators
2.4.2 Negative Allosteric Modulators
2.4.3 Non-modulating Detection Reagents
2.4.4 Metabotropic Glutamate Receptor 2 Sales by Receptor Pharmacological Action
2.4.4.1 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Receptor Pharmacological Action (2021-2026)
2.4.4.2 Global Metabotropic Glutamate Receptor 2 Revenue and Market Share by Receptor Pharmacological Action (2021-2026)
2.4.4.3 Global Metabotropic Glutamate Receptor 2 Sale Price by Receptor Pharmacological Action (2021-2026)
2.5 Metabotropic Glutamate Receptor 2 Segment by Antibody Generation Technology
2.5.1 Polyclonal Antibodies
2.5.2 Hybridoma Monoclonal Antibodies
2.5.3 Recombinant Monoclonal Antibodies
2.5.4 Metabotropic Glutamate Receptor 2 Sales by Antibody Generation Technology
2.5.4.1 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Antibody Generation Technology (2021-2026)
2.5.4.2 Global Metabotropic Glutamate Receptor 2 Revenue and Market Share by Antibody Generation Technology (2021-2026)
2.5.4.3 Global Metabotropic Glutamate Receptor 2 Sale Price by Antibody Generation Technology (2021-2026)
2.6 Metabotropic Glutamate Receptor 2 Segment by Application
2.6.1 Anxiety Disorders
2.6.2 Depression
2.6.3 Schizophrenia
2.6.4 Chronic Pain
2.6.5 Others
2.6.6 Metabotropic Glutamate Receptor 2 Sales by Application
2.6.6.1 Global Metabotropic Glutamate Receptor 2 Sale Market Share by Application (2021-2026)
2.6.6.2 Global Metabotropic Glutamate Receptor 2 Revenue and Market Share by Application (2021-2026)
2.6.6.3 Global Metabotropic Glutamate Receptor 2 Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Metabotropic Glutamate Receptor 2 Breakdown Data by Company
3.1.1 Global Metabotropic Glutamate Receptor 2 Annual Sales by Company (2021-2026)
3.1.2 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Company (2021-2026)
3.2 Global Metabotropic Glutamate Receptor 2 Annual Revenue by Company (2021-2026)
3.2.1 Global Metabotropic Glutamate Receptor 2 Revenue by Company (2021-2026)
3.2.2 Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Company (2021-2026)
3.3 Global Metabotropic Glutamate Receptor 2 Sale Price by Company
3.4 Key Manufacturers Metabotropic Glutamate Receptor 2 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Metabotropic Glutamate Receptor 2 Product Location Distribution
3.4.2 Players Metabotropic Glutamate Receptor 2 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR METABOTROPIC GLUTAMATE RECEPTOR 2 BY GEOGRAPHIC REGION
4.1 World Historic Metabotropic Glutamate Receptor 2 Market Size by Geographic Region (2021-2026)
4.1.1 Global Metabotropic Glutamate Receptor 2 Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Metabotropic Glutamate Receptor 2 Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Metabotropic Glutamate Receptor 2 Market Size by Country/Region (2021-2026)
4.2.1 Global Metabotropic Glutamate Receptor 2 Annual Sales by Country/Region (2021-2026)
4.2.2 Global Metabotropic Glutamate Receptor 2 Annual Revenue by Country/Region (2021-2026)
4.3 Americas Metabotropic Glutamate Receptor 2 Sales Growth
4.4 APAC Metabotropic Glutamate Receptor 2 Sales Growth
4.5 Europe Metabotropic Glutamate Receptor 2 Sales Growth
4.6 Middle East & Africa Metabotropic Glutamate Receptor 2 Sales Growth
5 AMERICAS
5.1 Americas Metabotropic Glutamate Receptor 2 Sales by Country
5.1.1 Americas Metabotropic Glutamate Receptor 2 Sales by Country (2021-2026)
5.1.2 Americas Metabotropic Glutamate Receptor 2 Revenue by Country (2021-2026)
5.2 Americas Metabotropic Glutamate Receptor 2 Sales by Type (2021-2026)
5.3 Americas Metabotropic Glutamate Receptor 2 Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Metabotropic Glutamate Receptor 2 Sales by Region
6.1.1 APAC Metabotropic Glutamate Receptor 2 Sales by Region (2021-2026)
6.1.2 APAC Metabotropic Glutamate Receptor 2 Revenue by Region (2021-2026)
6.2 APAC Metabotropic Glutamate Receptor 2 Sales by Type (2021-2026)
6.3 APAC Metabotropic Glutamate Receptor 2 Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Metabotropic Glutamate Receptor 2 by Country
7.1.1 Europe Metabotropic Glutamate Receptor 2 Sales by Country (2021-2026)
7.1.2 Europe Metabotropic Glutamate Receptor 2 Revenue by Country (2021-2026)
7.2 Europe Metabotropic Glutamate Receptor 2 Sales by Type (2021-2026)
7.3 Europe Metabotropic Glutamate Receptor 2 Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Metabotropic Glutamate Receptor 2 by Country
8.1.1 Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Country (2021-2026)
8.1.2 Middle East & Africa Metabotropic Glutamate Receptor 2 Revenue by Country (2021-2026)
8.2 Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Type (2021-2026)
8.3 Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Metabotropic Glutamate Receptor
10.3 Manufacturing Process Analysis of Metabotropic Glutamate Receptor
10.4 Industry Chain Structure of Metabotropic Glutamate Receptor
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Metabotropic Glutamate Receptor 2 Distributors
11.3 Metabotropic Glutamate Receptor 2 Customer
12 WORLD FORECAST REVIEW FOR METABOTROPIC GLUTAMATE RECEPTOR 2 BY GEOGRAPHIC REGION
12.1 Global Metabotropic Glutamate Receptor 2 Market Size Forecast by Region
12.1.1 Global Metabotropic Glutamate Receptor 2 Forecast by Region (2027-2032)
12.1.2 Global Metabotropic Glutamate Receptor 2 Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Metabotropic Glutamate Receptor 2 Forecast by Type (2027-2032)
12.7 Global Metabotropic Glutamate Receptor 2 Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Thermo Fisher Scientific
13.1.1 Thermo Fisher Scientific Company Information
13.1.2 Thermo Fisher Scientific Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.1.3 Thermo Fisher Scientific Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Thermo Fisher Scientific Main Business Overview
13.1.5 Thermo Fisher Scientific Latest Developments
13.2 Merck KGaA
13.2.1 Merck KGaA Company Information
13.2.2 Merck KGaA Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.2.3 Merck KGaA Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Merck KGaA Main Business Overview
13.2.5 Merck KGaA Latest Developments
13.3 Danaher
13.3.1 Danaher Company Information
13.3.2 Danaher Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.3.3 Danaher Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Danaher Main Business Overview
13.3.5 Danaher Latest Developments
13.4 Bio-Techne
13.4.1 Bio-Techne Company Information
13.4.2 Bio-Techne Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.4.3 Bio-Techne Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Bio-Techne Main Business Overview
13.4.5 Bio-Techne Latest Developments
13.5 Cell Signaling Technology
13.5.1 Cell Signaling Technology Company Information
13.5.2 Cell Signaling Technology Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.5.3 Cell Signaling Technology Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Cell Signaling Technology Main Business Overview
13.5.5 Cell Signaling Technology Latest Developments
13.6 Proteintech
13.6.1 Proteintech Company Information
13.6.2 Proteintech Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.6.3 Proteintech Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Proteintech Main Business Overview
13.6.5 Proteintech Latest Developments
13.7 OriGene Technologies
13.7.1 OriGene Technologies Company Information
13.7.2 OriGene Technologies Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.7.3 OriGene Technologies Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 OriGene Technologies Main Business Overview
13.7.5 OriGene Technologies Latest Developments
13.8 GeneTex
13.8.1 GeneTex Company Information
13.8.2 GeneTex Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.8.3 GeneTex Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 GeneTex Main Business Overview
13.8.5 GeneTex Latest Developments
13.9 Santa Cruz Biotechnology
13.9.1 Santa Cruz Biotechnology Company Information
13.9.2 Santa Cruz Biotechnology Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.9.3 Santa Cruz Biotechnology Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Santa Cruz Biotechnology Main Business Overview
13.9.5 Santa Cruz Biotechnology Latest Developments
13.10 Cayman Chemical
13.10.1 Cayman Chemical Company Information
13.10.2 Cayman Chemical Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.10.3 Cayman Chemical Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Cayman Chemical Main Business Overview
13.10.5 Cayman Chemical Latest Developments
13.11 MedChemExpress
13.11.1 MedChemExpress Company Information
13.11.2 MedChemExpress Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.11.3 MedChemExpress Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 MedChemExpress Main Business Overview
13.11.5 MedChemExpress Latest Developments
13.12 Selleck Chemicals
13.12.1 Selleck Chemicals Company Information
13.12.2 Selleck Chemicals Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.12.3 Selleck Chemicals Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Selleck Chemicals Main Business Overview
13.12.5 Selleck Chemicals Latest Developments
13.13 TargetMol
13.13.1 TargetMol Company Information
13.13.2 TargetMol Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.13.3 TargetMol Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 TargetMol Main Business Overview
13.13.5 TargetMol Latest Developments
13.14 ApexBio
13.14.1 ApexBio Company Information
13.14.2 ApexBio Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.14.3 ApexBio Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 ApexBio Main Business Overview
13.14.5 ApexBio Latest Developments
13.15 GLPBIO
13.15.1 GLPBIO Company Information
13.15.2 GLPBIO Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.15.3 GLPBIO Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 GLPBIO Main Business Overview
13.15.5 GLPBIO Latest Developments
13.16 Adooq Bioscience
13.16.1 Adooq Bioscience Company Information
13.16.2 Adooq Bioscience Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.16.3 Adooq Bioscience Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Adooq Bioscience Main Business Overview
13.16.5 Adooq Bioscience Latest Developments
13.17 MedKoo Biosciences
13.17.1 MedKoo Biosciences Company Information
13.17.2 MedKoo Biosciences Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.17.3 MedKoo Biosciences Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 MedKoo Biosciences Main Business Overview
13.17.5 MedKoo Biosciences Latest Developments
13.18 MyBioSource
13.18.1 MyBioSource Company Information
13.18.2 MyBioSource Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.18.3 MyBioSource Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 MyBioSource Main Business Overview
13.18.5 MyBioSource Latest Developments
13.19 Aviva Systems Biology
13.19.1 Aviva Systems Biology Company Information
13.19.2 Aviva Systems Biology Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.19.3 Aviva Systems Biology Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Aviva Systems Biology Main Business Overview
13.19.5 Aviva Systems Biology Latest Developments
13.20 Signalway Antibody
13.20.1 Signalway Antibody Company Information
13.20.2 Signalway Antibody Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.20.3 Signalway Antibody Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Signalway Antibody Main Business Overview
13.20.5 Signalway Antibody Latest Developments
13.21 NSJ Bioreagents
13.21.1 NSJ Bioreagents Company Information
13.21.2 NSJ Bioreagents Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.21.3 NSJ Bioreagents Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 NSJ Bioreagents Main Business Overview
13.21.5 NSJ Bioreagents Latest Developments
13.22 Antibodies Incorporated
13.22.1 Antibodies Incorporated Company Information
13.22.2 Antibodies Incorporated Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.22.3 Antibodies Incorporated Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Antibodies Incorporated Main Business Overview
13.22.5 Antibodies Incorporated Latest Developments
13.23 Biorbyt
13.23.1 Biorbyt Company Information
13.23.2 Biorbyt Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.23.3 Biorbyt Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Biorbyt Main Business Overview
13.23.5 Biorbyt Latest Developments
13.24 Abbexa
13.24.1 Abbexa Company Information
13.24.2 Abbexa Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.24.3 Abbexa Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 Abbexa Main Business Overview
13.24.5 Abbexa Latest Developments
13.25 AMSBIO
13.25.1 AMSBIO Company Information
13.25.2 AMSBIO Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.25.3 AMSBIO Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.25.4 AMSBIO Main Business Overview
13.25.5 AMSBIO Latest Developments
13.26 Tocris Bioscience
13.26.1 Tocris Bioscience Company Information
13.26.2 Tocris Bioscience Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.26.3 Tocris Bioscience Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.26.4 Tocris Bioscience Main Business Overview
13.26.5 Tocris Bioscience Latest Developments
13.27 Hello Bio
13.27.1 Hello Bio Company Information
13.27.2 Hello Bio Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.27.3 Hello Bio Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.27.4 Hello Bio Main Business Overview
13.27.5 Hello Bio Latest Developments
13.28 Axon Medchem
13.28.1 Axon Medchem Company Information
13.28.2 Axon Medchem Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.28.3 Axon Medchem Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.28.4 Axon Medchem Main Business Overview
13.28.5 Axon Medchem Latest Developments
13.29 Alomone Labs?IL?
13.29.1 Alomone Labs?IL? Company Information
13.29.2 Alomone Labs?IL? Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.29.3 Alomone Labs?IL? Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.29.4 Alomone Labs?IL? Main Business Overview
13.29.5 Alomone Labs?IL? Latest Developments
13.30 FUJIFILM Wako Pure Chemical
13.30.1 FUJIFILM Wako Pure Chemical Company Information
13.30.2 FUJIFILM Wako Pure Chemical Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.30.3 FUJIFILM Wako Pure Chemical Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.30.4 FUJIFILM Wako Pure Chemical Main Business Overview
13.30.5 FUJIFILM Wako Pure Chemical Latest Developments
13.31 Sumitomo Pharma
13.31.1 Sumitomo Pharma Company Information
13.31.2 Sumitomo Pharma Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.31.3 Sumitomo Pharma Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.31.4 Sumitomo Pharma Main Business Overview
13.31.5 Sumitomo Pharma Latest Developments
13.32 Boehringer Ingelheim
13.32.1 Boehringer Ingelheim Company Information
13.32.2 Boehringer Ingelheim Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.32.3 Boehringer Ingelheim Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.32.4 Boehringer Ingelheim Main Business Overview
13.32.5 Boehringer Ingelheim Latest Developments
13.33 AstraZeneca
13.33.1 AstraZeneca Company Information
13.33.2 AstraZeneca Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.33.3 AstraZeneca Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.33.4 AstraZeneca Main Business Overview
13.33.5 AstraZeneca Latest Developments
13.34 Denovo Biopharma
13.34.1 Denovo Biopharma Company Information
13.34.2 Denovo Biopharma Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.34.3 Denovo Biopharma Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.34.4 Denovo Biopharma Main Business Overview
13.34.5 Denovo Biopharma Latest Developments
13.35 Addex Therapeutics
13.35.1 Addex Therapeutics Company Information
13.35.2 Addex Therapeutics Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.35.3 Addex Therapeutics Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.35.4 Addex Therapeutics Main Business Overview
13.35.5 Addex Therapeutics Latest Developments
13.36 Noema Pharma
13.36.1 Noema Pharma Company Information
13.36.2 Noema Pharma Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.36.3 Noema Pharma Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.36.4 Noema Pharma Main Business Overview
13.36.5 Noema Pharma Latest Developments
13.37 BOC Sciences
13.37.1 BOC Sciences Company Information
13.37.2 BOC Sciences Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.37.3 BOC Sciences Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.37.4 BOC Sciences Main Business Overview
13.37.5 BOC Sciences Latest Developments
13.38 CUSABIO
13.38.1 CUSABIO Company Information
13.38.2 CUSABIO Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.38.3 CUSABIO Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.38.4 CUSABIO Main Business Overview
13.38.5 CUSABIO Latest Developments
13.39 HUABIO
13.39.1 HUABIO Company Information
13.39.2 HUABIO Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.39.3 HUABIO Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.39.4 HUABIO Main Business Overview
13.39.5 HUABIO Latest Developments
13.40 Abbkine
13.40.1 Abbkine Company Information
13.40.2 Abbkine Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.40.3 Abbkine Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.40.4 Abbkine Main Business Overview
13.40.5 Abbkine Latest Developments
13.41 FineTest
13.41.1 FineTest Company Information
13.41.2 FineTest Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.41.3 FineTest Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.41.4 FineTest Main Business Overview
13.41.5 FineTest Latest Developments
13.42 Bioss Antibodies
13.42.1 Bioss Antibodies Company Information
13.42.2 Bioss Antibodies Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.42.3 Bioss Antibodies Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.42.4 Bioss Antibodies Main Business Overview
13.42.5 Bioss Antibodies Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Metabotropic Glutamate Receptor 2 Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Metabotropic Glutamate Receptor 2 by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Metabotropic Glutamate Receptor 2 by Country/Region, 2021, 2025 & 2032
2.2 Metabotropic Glutamate Receptor 2 Segment by Type
2.2.1 LY-487379
2.2.2 JNJ-40411813
2.2.3 ADX71149
2.2.4 Others
2.2.5 Metabotropic Glutamate Receptor 2 Sales by Type
2.2.5.1 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2021-2026)
2.2.5.2 Global Metabotropic Glutamate Receptor 2 Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Metabotropic Glutamate Receptor 2 Sale Price by Type (2021-2026)
2.3 Metabotropic Glutamate Receptor 2 Segment by Biological Material Type
2.3.1 Protein-based Reagents
2.3.2 Cell-based Products
2.3.3 Synthetic Chemical Products
2.3.4 Metabotropic Glutamate Receptor 2 Sales by Biological Material Type
2.3.4.1 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Biological Material Type (2021-2026)
2.3.4.2 Global Metabotropic Glutamate Receptor 2 Revenue and Market Share by Biological Material Type (2021-2026)
2.3.4.3 Global Metabotropic Glutamate Receptor 2 Sale Price by Biological Material Type (2021-2026)
2.4 Metabotropic Glutamate Receptor 2 Segment by Receptor Pharmacological Action
2.4.1 Positive Allosteric Modulators
2.4.2 Negative Allosteric Modulators
2.4.3 Non-modulating Detection Reagents
2.4.4 Metabotropic Glutamate Receptor 2 Sales by Receptor Pharmacological Action
2.4.4.1 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Receptor Pharmacological Action (2021-2026)
2.4.4.2 Global Metabotropic Glutamate Receptor 2 Revenue and Market Share by Receptor Pharmacological Action (2021-2026)
2.4.4.3 Global Metabotropic Glutamate Receptor 2 Sale Price by Receptor Pharmacological Action (2021-2026)
2.5 Metabotropic Glutamate Receptor 2 Segment by Antibody Generation Technology
2.5.1 Polyclonal Antibodies
2.5.2 Hybridoma Monoclonal Antibodies
2.5.3 Recombinant Monoclonal Antibodies
2.5.4 Metabotropic Glutamate Receptor 2 Sales by Antibody Generation Technology
2.5.4.1 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Antibody Generation Technology (2021-2026)
2.5.4.2 Global Metabotropic Glutamate Receptor 2 Revenue and Market Share by Antibody Generation Technology (2021-2026)
2.5.4.3 Global Metabotropic Glutamate Receptor 2 Sale Price by Antibody Generation Technology (2021-2026)
2.6 Metabotropic Glutamate Receptor 2 Segment by Application
2.6.1 Anxiety Disorders
2.6.2 Depression
2.6.3 Schizophrenia
2.6.4 Chronic Pain
2.6.5 Others
2.6.6 Metabotropic Glutamate Receptor 2 Sales by Application
2.6.6.1 Global Metabotropic Glutamate Receptor 2 Sale Market Share by Application (2021-2026)
2.6.6.2 Global Metabotropic Glutamate Receptor 2 Revenue and Market Share by Application (2021-2026)
2.6.6.3 Global Metabotropic Glutamate Receptor 2 Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Metabotropic Glutamate Receptor 2 Breakdown Data by Company
3.1.1 Global Metabotropic Glutamate Receptor 2 Annual Sales by Company (2021-2026)
3.1.2 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Company (2021-2026)
3.2 Global Metabotropic Glutamate Receptor 2 Annual Revenue by Company (2021-2026)
3.2.1 Global Metabotropic Glutamate Receptor 2 Revenue by Company (2021-2026)
3.2.2 Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Company (2021-2026)
3.3 Global Metabotropic Glutamate Receptor 2 Sale Price by Company
3.4 Key Manufacturers Metabotropic Glutamate Receptor 2 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Metabotropic Glutamate Receptor 2 Product Location Distribution
3.4.2 Players Metabotropic Glutamate Receptor 2 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR METABOTROPIC GLUTAMATE RECEPTOR 2 BY GEOGRAPHIC REGION
4.1 World Historic Metabotropic Glutamate Receptor 2 Market Size by Geographic Region (2021-2026)
4.1.1 Global Metabotropic Glutamate Receptor 2 Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Metabotropic Glutamate Receptor 2 Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Metabotropic Glutamate Receptor 2 Market Size by Country/Region (2021-2026)
4.2.1 Global Metabotropic Glutamate Receptor 2 Annual Sales by Country/Region (2021-2026)
4.2.2 Global Metabotropic Glutamate Receptor 2 Annual Revenue by Country/Region (2021-2026)
4.3 Americas Metabotropic Glutamate Receptor 2 Sales Growth
4.4 APAC Metabotropic Glutamate Receptor 2 Sales Growth
4.5 Europe Metabotropic Glutamate Receptor 2 Sales Growth
4.6 Middle East & Africa Metabotropic Glutamate Receptor 2 Sales Growth
5 AMERICAS
5.1 Americas Metabotropic Glutamate Receptor 2 Sales by Country
5.1.1 Americas Metabotropic Glutamate Receptor 2 Sales by Country (2021-2026)
5.1.2 Americas Metabotropic Glutamate Receptor 2 Revenue by Country (2021-2026)
5.2 Americas Metabotropic Glutamate Receptor 2 Sales by Type (2021-2026)
5.3 Americas Metabotropic Glutamate Receptor 2 Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Metabotropic Glutamate Receptor 2 Sales by Region
6.1.1 APAC Metabotropic Glutamate Receptor 2 Sales by Region (2021-2026)
6.1.2 APAC Metabotropic Glutamate Receptor 2 Revenue by Region (2021-2026)
6.2 APAC Metabotropic Glutamate Receptor 2 Sales by Type (2021-2026)
6.3 APAC Metabotropic Glutamate Receptor 2 Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Metabotropic Glutamate Receptor 2 by Country
7.1.1 Europe Metabotropic Glutamate Receptor 2 Sales by Country (2021-2026)
7.1.2 Europe Metabotropic Glutamate Receptor 2 Revenue by Country (2021-2026)
7.2 Europe Metabotropic Glutamate Receptor 2 Sales by Type (2021-2026)
7.3 Europe Metabotropic Glutamate Receptor 2 Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Metabotropic Glutamate Receptor 2 by Country
8.1.1 Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Country (2021-2026)
8.1.2 Middle East & Africa Metabotropic Glutamate Receptor 2 Revenue by Country (2021-2026)
8.2 Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Type (2021-2026)
8.3 Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Metabotropic Glutamate Receptor
10.3 Manufacturing Process Analysis of Metabotropic Glutamate Receptor
10.4 Industry Chain Structure of Metabotropic Glutamate Receptor
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Metabotropic Glutamate Receptor 2 Distributors
11.3 Metabotropic Glutamate Receptor 2 Customer
12 WORLD FORECAST REVIEW FOR METABOTROPIC GLUTAMATE RECEPTOR 2 BY GEOGRAPHIC REGION
12.1 Global Metabotropic Glutamate Receptor 2 Market Size Forecast by Region
12.1.1 Global Metabotropic Glutamate Receptor 2 Forecast by Region (2027-2032)
12.1.2 Global Metabotropic Glutamate Receptor 2 Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Metabotropic Glutamate Receptor 2 Forecast by Type (2027-2032)
12.7 Global Metabotropic Glutamate Receptor 2 Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Thermo Fisher Scientific
13.1.1 Thermo Fisher Scientific Company Information
13.1.2 Thermo Fisher Scientific Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.1.3 Thermo Fisher Scientific Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Thermo Fisher Scientific Main Business Overview
13.1.5 Thermo Fisher Scientific Latest Developments
13.2 Merck KGaA
13.2.1 Merck KGaA Company Information
13.2.2 Merck KGaA Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.2.3 Merck KGaA Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Merck KGaA Main Business Overview
13.2.5 Merck KGaA Latest Developments
13.3 Danaher
13.3.1 Danaher Company Information
13.3.2 Danaher Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.3.3 Danaher Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Danaher Main Business Overview
13.3.5 Danaher Latest Developments
13.4 Bio-Techne
13.4.1 Bio-Techne Company Information
13.4.2 Bio-Techne Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.4.3 Bio-Techne Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Bio-Techne Main Business Overview
13.4.5 Bio-Techne Latest Developments
13.5 Cell Signaling Technology
13.5.1 Cell Signaling Technology Company Information
13.5.2 Cell Signaling Technology Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.5.3 Cell Signaling Technology Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Cell Signaling Technology Main Business Overview
13.5.5 Cell Signaling Technology Latest Developments
13.6 Proteintech
13.6.1 Proteintech Company Information
13.6.2 Proteintech Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.6.3 Proteintech Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Proteintech Main Business Overview
13.6.5 Proteintech Latest Developments
13.7 OriGene Technologies
13.7.1 OriGene Technologies Company Information
13.7.2 OriGene Technologies Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.7.3 OriGene Technologies Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 OriGene Technologies Main Business Overview
13.7.5 OriGene Technologies Latest Developments
13.8 GeneTex
13.8.1 GeneTex Company Information
13.8.2 GeneTex Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.8.3 GeneTex Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 GeneTex Main Business Overview
13.8.5 GeneTex Latest Developments
13.9 Santa Cruz Biotechnology
13.9.1 Santa Cruz Biotechnology Company Information
13.9.2 Santa Cruz Biotechnology Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.9.3 Santa Cruz Biotechnology Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Santa Cruz Biotechnology Main Business Overview
13.9.5 Santa Cruz Biotechnology Latest Developments
13.10 Cayman Chemical
13.10.1 Cayman Chemical Company Information
13.10.2 Cayman Chemical Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.10.3 Cayman Chemical Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Cayman Chemical Main Business Overview
13.10.5 Cayman Chemical Latest Developments
13.11 MedChemExpress
13.11.1 MedChemExpress Company Information
13.11.2 MedChemExpress Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.11.3 MedChemExpress Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 MedChemExpress Main Business Overview
13.11.5 MedChemExpress Latest Developments
13.12 Selleck Chemicals
13.12.1 Selleck Chemicals Company Information
13.12.2 Selleck Chemicals Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.12.3 Selleck Chemicals Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Selleck Chemicals Main Business Overview
13.12.5 Selleck Chemicals Latest Developments
13.13 TargetMol
13.13.1 TargetMol Company Information
13.13.2 TargetMol Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.13.3 TargetMol Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 TargetMol Main Business Overview
13.13.5 TargetMol Latest Developments
13.14 ApexBio
13.14.1 ApexBio Company Information
13.14.2 ApexBio Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.14.3 ApexBio Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 ApexBio Main Business Overview
13.14.5 ApexBio Latest Developments
13.15 GLPBIO
13.15.1 GLPBIO Company Information
13.15.2 GLPBIO Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.15.3 GLPBIO Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 GLPBIO Main Business Overview
13.15.5 GLPBIO Latest Developments
13.16 Adooq Bioscience
13.16.1 Adooq Bioscience Company Information
13.16.2 Adooq Bioscience Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.16.3 Adooq Bioscience Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Adooq Bioscience Main Business Overview
13.16.5 Adooq Bioscience Latest Developments
13.17 MedKoo Biosciences
13.17.1 MedKoo Biosciences Company Information
13.17.2 MedKoo Biosciences Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.17.3 MedKoo Biosciences Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 MedKoo Biosciences Main Business Overview
13.17.5 MedKoo Biosciences Latest Developments
13.18 MyBioSource
13.18.1 MyBioSource Company Information
13.18.2 MyBioSource Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.18.3 MyBioSource Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 MyBioSource Main Business Overview
13.18.5 MyBioSource Latest Developments
13.19 Aviva Systems Biology
13.19.1 Aviva Systems Biology Company Information
13.19.2 Aviva Systems Biology Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.19.3 Aviva Systems Biology Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Aviva Systems Biology Main Business Overview
13.19.5 Aviva Systems Biology Latest Developments
13.20 Signalway Antibody
13.20.1 Signalway Antibody Company Information
13.20.2 Signalway Antibody Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.20.3 Signalway Antibody Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Signalway Antibody Main Business Overview
13.20.5 Signalway Antibody Latest Developments
13.21 NSJ Bioreagents
13.21.1 NSJ Bioreagents Company Information
13.21.2 NSJ Bioreagents Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.21.3 NSJ Bioreagents Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 NSJ Bioreagents Main Business Overview
13.21.5 NSJ Bioreagents Latest Developments
13.22 Antibodies Incorporated
13.22.1 Antibodies Incorporated Company Information
13.22.2 Antibodies Incorporated Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.22.3 Antibodies Incorporated Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Antibodies Incorporated Main Business Overview
13.22.5 Antibodies Incorporated Latest Developments
13.23 Biorbyt
13.23.1 Biorbyt Company Information
13.23.2 Biorbyt Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.23.3 Biorbyt Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Biorbyt Main Business Overview
13.23.5 Biorbyt Latest Developments
13.24 Abbexa
13.24.1 Abbexa Company Information
13.24.2 Abbexa Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.24.3 Abbexa Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 Abbexa Main Business Overview
13.24.5 Abbexa Latest Developments
13.25 AMSBIO
13.25.1 AMSBIO Company Information
13.25.2 AMSBIO Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.25.3 AMSBIO Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.25.4 AMSBIO Main Business Overview
13.25.5 AMSBIO Latest Developments
13.26 Tocris Bioscience
13.26.1 Tocris Bioscience Company Information
13.26.2 Tocris Bioscience Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.26.3 Tocris Bioscience Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.26.4 Tocris Bioscience Main Business Overview
13.26.5 Tocris Bioscience Latest Developments
13.27 Hello Bio
13.27.1 Hello Bio Company Information
13.27.2 Hello Bio Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.27.3 Hello Bio Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.27.4 Hello Bio Main Business Overview
13.27.5 Hello Bio Latest Developments
13.28 Axon Medchem
13.28.1 Axon Medchem Company Information
13.28.2 Axon Medchem Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.28.3 Axon Medchem Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.28.4 Axon Medchem Main Business Overview
13.28.5 Axon Medchem Latest Developments
13.29 Alomone Labs?IL?
13.29.1 Alomone Labs?IL? Company Information
13.29.2 Alomone Labs?IL? Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.29.3 Alomone Labs?IL? Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.29.4 Alomone Labs?IL? Main Business Overview
13.29.5 Alomone Labs?IL? Latest Developments
13.30 FUJIFILM Wako Pure Chemical
13.30.1 FUJIFILM Wako Pure Chemical Company Information
13.30.2 FUJIFILM Wako Pure Chemical Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.30.3 FUJIFILM Wako Pure Chemical Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.30.4 FUJIFILM Wako Pure Chemical Main Business Overview
13.30.5 FUJIFILM Wako Pure Chemical Latest Developments
13.31 Sumitomo Pharma
13.31.1 Sumitomo Pharma Company Information
13.31.2 Sumitomo Pharma Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.31.3 Sumitomo Pharma Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.31.4 Sumitomo Pharma Main Business Overview
13.31.5 Sumitomo Pharma Latest Developments
13.32 Boehringer Ingelheim
13.32.1 Boehringer Ingelheim Company Information
13.32.2 Boehringer Ingelheim Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.32.3 Boehringer Ingelheim Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.32.4 Boehringer Ingelheim Main Business Overview
13.32.5 Boehringer Ingelheim Latest Developments
13.33 AstraZeneca
13.33.1 AstraZeneca Company Information
13.33.2 AstraZeneca Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.33.3 AstraZeneca Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.33.4 AstraZeneca Main Business Overview
13.33.5 AstraZeneca Latest Developments
13.34 Denovo Biopharma
13.34.1 Denovo Biopharma Company Information
13.34.2 Denovo Biopharma Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.34.3 Denovo Biopharma Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.34.4 Denovo Biopharma Main Business Overview
13.34.5 Denovo Biopharma Latest Developments
13.35 Addex Therapeutics
13.35.1 Addex Therapeutics Company Information
13.35.2 Addex Therapeutics Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.35.3 Addex Therapeutics Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.35.4 Addex Therapeutics Main Business Overview
13.35.5 Addex Therapeutics Latest Developments
13.36 Noema Pharma
13.36.1 Noema Pharma Company Information
13.36.2 Noema Pharma Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.36.3 Noema Pharma Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.36.4 Noema Pharma Main Business Overview
13.36.5 Noema Pharma Latest Developments
13.37 BOC Sciences
13.37.1 BOC Sciences Company Information
13.37.2 BOC Sciences Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.37.3 BOC Sciences Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.37.4 BOC Sciences Main Business Overview
13.37.5 BOC Sciences Latest Developments
13.38 CUSABIO
13.38.1 CUSABIO Company Information
13.38.2 CUSABIO Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.38.3 CUSABIO Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.38.4 CUSABIO Main Business Overview
13.38.5 CUSABIO Latest Developments
13.39 HUABIO
13.39.1 HUABIO Company Information
13.39.2 HUABIO Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.39.3 HUABIO Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.39.4 HUABIO Main Business Overview
13.39.5 HUABIO Latest Developments
13.40 Abbkine
13.40.1 Abbkine Company Information
13.40.2 Abbkine Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.40.3 Abbkine Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.40.4 Abbkine Main Business Overview
13.40.5 Abbkine Latest Developments
13.41 FineTest
13.41.1 FineTest Company Information
13.41.2 FineTest Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.41.3 FineTest Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.41.4 FineTest Main Business Overview
13.41.5 FineTest Latest Developments
13.42 Bioss Antibodies
13.42.1 Bioss Antibodies Company Information
13.42.2 Bioss Antibodies Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
13.42.3 Bioss Antibodies Metabotropic Glutamate Receptor 2 Sales, Revenue, Price and Gross Margin (2021-2026)
13.42.4 Bioss Antibodies Main Business Overview
13.42.5 Bioss Antibodies Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Metabotropic Glutamate Receptor 2 Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Metabotropic Glutamate Receptor 2 Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of LY-487379
Table 4. Major Players of JNJ-40411813
Table 5. Major Players of ADX71149
Table 6. Major Players of Others
Table 7. Global Metabotropic Glutamate Receptor 2 Sales by Type (2021-2026) & (K Pcs)
Table 8. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2021-2026)
Table 9. Global Metabotropic Glutamate Receptor 2 Revenue by Type (2021-2026) & ($ million)
Table 10. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2021-2026)
Table 11. Global Metabotropic Glutamate Receptor 2 Sale Price by Type (2021-2026) & (USD/Pcs)
Table 12. Major Players of Protein-based Reagents
Table 13. Major Players of Cell-based Products
Table 14. Major Players of Synthetic Chemical Products
Table 15. Global Metabotropic Glutamate Receptor 2 Sales by Biological Material Type (2021-2026) & (K Pcs)
Table 16. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Biological Material Type (2021-2026)
Table 17. Global Metabotropic Glutamate Receptor 2 Revenue by Biological Material Type (2021-2026) & ($ million)
Table 18. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Biological Material Type (2021-2026)
Table 19. Global Metabotropic Glutamate Receptor 2 Sale Price by Biological Material Type (2021-2026) & (USD/Pcs)
Table 20. Major Players of Positive Allosteric Modulators
Table 21. Major Players of Negative Allosteric Modulators
Table 22. Major Players of Non-modulating Detection Reagents
Table 23. Global Metabotropic Glutamate Receptor 2 Sales by Receptor Pharmacological Action (2021-2026) & (K Pcs)
Table 24. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Receptor Pharmacological Action (2021-2026)
Table 25. Global Metabotropic Glutamate Receptor 2 Revenue by Receptor Pharmacological Action (2021-2026) & ($ million)
Table 26. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Receptor Pharmacological Action (2021-2026)
Table 27. Global Metabotropic Glutamate Receptor 2 Sale Price by Receptor Pharmacological Action (2021-2026) & (USD/Pcs)
Table 28. Major Players of Polyclonal Antibodies
Table 29. Major Players of Hybridoma Monoclonal Antibodies
Table 30. Major Players of Recombinant Monoclonal Antibodies
Table 31. Global Metabotropic Glutamate Receptor 2 Sales by Antibody Generation Technology (2021-2026) & (K Pcs)
Table 32. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Antibody Generation Technology (2021-2026)
Table 33. Global Metabotropic Glutamate Receptor 2 Revenue by Antibody Generation Technology (2021-2026) & ($ million)
Table 34. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Antibody Generation Technology (2021-2026)
Table 35. Global Metabotropic Glutamate Receptor 2 Sale Price by Antibody Generation Technology (2021-2026) & (USD/Pcs)
Table 36. Global Metabotropic Glutamate Receptor 2 Sale by Application (2021-2026) & (K Pcs)
Table 37. Global Metabotropic Glutamate Receptor 2 Sale Market Share by Application (2021-2026)
Table 38. Global Metabotropic Glutamate Receptor 2 Revenue by Application (2021-2026) & ($ million)
Table 39. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Application (2021-2026)
Table 40. Global Metabotropic Glutamate Receptor 2 Sale Price by Application (2021-2026) & (USD/Pcs)
Table 41. Global Metabotropic Glutamate Receptor 2 Sales by Company (2021-2026) & (K Pcs)
Table 42. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Company (2021-2026)
Table 43. Global Metabotropic Glutamate Receptor 2 Revenue by Company (2021-2026) & ($ millions)
Table 44. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Company (2021-2026)
Table 45. Global Metabotropic Glutamate Receptor 2 Sale Price by Company (2021-2026) & (USD/Pcs)
Table 46. Key Manufacturers Metabotropic Glutamate Receptor 2 Producing Area Distribution and Sales Area
Table 47. Players Metabotropic Glutamate Receptor 2 Products Offered
Table 48. Metabotropic Glutamate Receptor 2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 49. New Products and Potential Entrants
Table 50. Market M&A Activity & Strategy
Table 51. Global Metabotropic Glutamate Receptor 2 Sales by Geographic Region (2021-2026) & (K Pcs)
Table 52. Global Metabotropic Glutamate Receptor 2 Sales Market Share Geographic Region (2021-2026)
Table 53. Global Metabotropic Glutamate Receptor 2 Revenue by Geographic Region (2021-2026) & ($ millions)
Table 54. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Geographic Region (2021-2026)
Table 55. Global Metabotropic Glutamate Receptor 2 Sales by Country/Region (2021-2026) & (K Pcs)
Table 56. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Country/Region (2021-2026)
Table 57. Global Metabotropic Glutamate Receptor 2 Revenue by Country/Region (2021-2026) & ($ millions)
Table 58. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Country/Region (2021-2026)
Table 59. Americas Metabotropic Glutamate Receptor 2 Sales by Country (2021-2026) & (K Pcs)
Table 60. Americas Metabotropic Glutamate Receptor 2 Sales Market Share by Country (2021-2026)
Table 61. Americas Metabotropic Glutamate Receptor 2 Revenue by Country (2021-2026) & ($ millions)
Table 62. Americas Metabotropic Glutamate Receptor 2 Sales by Type (2021-2026) & (K Pcs)
Table 63. Americas Metabotropic Glutamate Receptor 2 Sales by Application (2021-2026) & (K Pcs)
Table 64. APAC Metabotropic Glutamate Receptor 2 Sales by Region (2021-2026) & (K Pcs)
Table 65. APAC Metabotropic Glutamate Receptor 2 Sales Market Share by Region (2021-2026)
Table 66. APAC Metabotropic Glutamate Receptor 2 Revenue by Region (2021-2026) & ($ millions)
Table 67. APAC Metabotropic Glutamate Receptor 2 Sales by Type (2021-2026) & (K Pcs)
Table 68. APAC Metabotropic Glutamate Receptor 2 Sales by Application (2021-2026) & (K Pcs)
Table 69. Europe Metabotropic Glutamate Receptor 2 Sales by Country (2021-2026) & (K Pcs)
Table 70. Europe Metabotropic Glutamate Receptor 2 Revenue by Country (2021-2026) & ($ millions)
Table 71. Europe Metabotropic Glutamate Receptor 2 Sales by Type (2021-2026) & (K Pcs)
Table 72. Europe Metabotropic Glutamate Receptor 2 Sales by Application (2021-2026) & (K Pcs)
Table 73. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Country (2021-2026) & (K Pcs)
Table 74. Middle East & Africa Metabotropic Glutamate Receptor 2 Revenue Market Share by Country (2021-2026)
Table 75. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Type (2021-2026) & (K Pcs)
Table 76. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Application (2021-2026) & (K Pcs)
Table 77. Key Market Drivers & Growth Opportunities of Metabotropic Glutamate Receptor 2
Table 78. Key Market Challenges & Risks of Metabotropic Glutamate Receptor 2
Table 79. Key Industry Trends of Metabotropic Glutamate Receptor 2
Table 80. Metabotropic Glutamate Receptor 2 Raw Material
Table 81. Key Suppliers of Raw Materials
Table 82. Metabotropic Glutamate Receptor 2 Distributors List
Table 83. Metabotropic Glutamate Receptor 2 Customer List
Table 84. Global Metabotropic Glutamate Receptor 2 Sales Forecast by Region (2027-2032) & (K Pcs)
Table 85. Global Metabotropic Glutamate Receptor 2 Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Americas Metabotropic Glutamate Receptor 2 Sales Forecast by Country (2027-2032) & (K Pcs)
Table 87. Americas Metabotropic Glutamate Receptor 2 Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. APAC Metabotropic Glutamate Receptor 2 Sales Forecast by Region (2027-2032) & (K Pcs)
Table 89. APAC Metabotropic Glutamate Receptor 2 Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 90. Europe Metabotropic Glutamate Receptor 2 Sales Forecast by Country (2027-2032) & (K Pcs)
Table 91. Europe Metabotropic Glutamate Receptor 2 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 92. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales Forecast by Country (2027-2032) & (K Pcs)
Table 93. Middle East & Africa Metabotropic Glutamate Receptor 2 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 94. Global Metabotropic Glutamate Receptor 2 Sales Forecast by Type (2027-2032) & (K Pcs)
Table 95. Global Metabotropic Glutamate Receptor 2 Revenue Forecast by Type (2027-2032) & ($ millions)
Table 96. Global Metabotropic Glutamate Receptor 2 Sales Forecast by Application (2027-2032) & (K Pcs)
Table 97. Global Metabotropic Glutamate Receptor 2 Revenue Forecast by Application (2027-2032) & ($ millions)
Table 98. Thermo Fisher Scientific Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 99. Thermo Fisher Scientific Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 100. Thermo Fisher Scientific Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 101. Thermo Fisher Scientific Main Business
Table 102. Thermo Fisher Scientific Latest Developments
Table 103. Merck KGaA Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 104. Merck KGaA Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 105. Merck KGaA Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 106. Merck KGaA Main Business
Table 107. Merck KGaA Latest Developments
Table 108. Danaher Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 109. Danaher Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 110. Danaher Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 111. Danaher Main Business
Table 112. Danaher Latest Developments
Table 113. Bio-Techne Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 114. Bio-Techne Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 115. Bio-Techne Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 116. Bio-Techne Main Business
Table 117. Bio-Techne Latest Developments
Table 118. Cell Signaling Technology Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 119. Cell Signaling Technology Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 120. Cell Signaling Technology Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 121. Cell Signaling Technology Main Business
Table 122. Cell Signaling Technology Latest Developments
Table 123. Proteintech Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 124. Proteintech Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 125. Proteintech Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 126. Proteintech Main Business
Table 127. Proteintech Latest Developments
Table 128. OriGene Technologies Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 129. OriGene Technologies Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 130. OriGene Technologies Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 131. OriGene Technologies Main Business
Table 132. OriGene Technologies Latest Developments
Table 133. GeneTex Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 134. GeneTex Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 135. GeneTex Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 136. GeneTex Main Business
Table 137. GeneTex Latest Developments
Table 138. Santa Cruz Biotechnology Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 139. Santa Cruz Biotechnology Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 140. Santa Cruz Biotechnology Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 141. Santa Cruz Biotechnology Main Business
Table 142. Santa Cruz Biotechnology Latest Developments
Table 143. Cayman Chemical Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 144. Cayman Chemical Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 145. Cayman Chemical Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 146. Cayman Chemical Main Business
Table 147. Cayman Chemical Latest Developments
Table 148. MedChemExpress Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 149. MedChemExpress Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 150. MedChemExpress Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 151. MedChemExpress Main Business
Table 152. MedChemExpress Latest Developments
Table 153. Selleck Chemicals Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 154. Selleck Chemicals Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 155. Selleck Chemicals Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 156. Selleck Chemicals Main Business
Table 157. Selleck Chemicals Latest Developments
Table 158. TargetMol Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 159. TargetMol Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 160. TargetMol Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 161. TargetMol Main Business
Table 162. TargetMol Latest Developments
Table 163. ApexBio Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 164. ApexBio Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 165. ApexBio Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 166. ApexBio Main Business
Table 167. ApexBio Latest Developments
Table 168. GLPBIO Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 169. GLPBIO Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 170. GLPBIO Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 171. GLPBIO Main Business
Table 172. GLPBIO Latest Developments
Table 173. Adooq Bioscience Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 174. Adooq Bioscience Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 175. Adooq Bioscience Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 176. Adooq Bioscience Main Business
Table 177. Adooq Bioscience Latest Developments
Table 178. MedKoo Biosciences Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 179. MedKoo Biosciences Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 180. MedKoo Biosciences Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 181. MedKoo Biosciences Main Business
Table 182. MedKoo Biosciences Latest Developments
Table 183. MyBioSource Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 184. MyBioSource Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 185. MyBioSource Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 186. MyBioSource Main Business
Table 187. MyBioSource Latest Developments
Table 188. Aviva Systems Biology Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 189. Aviva Systems Biology Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 190. Aviva Systems Biology Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 191. Aviva Systems Biology Main Business
Table 192. Aviva Systems Biology Latest Developments
Table 193. Signalway Antibody Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 194. Signalway Antibody Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 195. Signalway Antibody Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 196. Signalway Antibody Main Business
Table 197. Signalway Antibody Latest Developments
Table 198. NSJ Bioreagents Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 199. NSJ Bioreagents Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 200. NSJ Bioreagents Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 201. NSJ Bioreagents Main Business
Table 202. NSJ Bioreagents Latest Developments
Table 203. Antibodies Incorporated Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 204. Antibodies Incorporated Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 205. Antibodies Incorporated Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 206. Antibodies Incorporated Main Business
Table 207. Antibodies Incorporated Latest Developments
Table 208. Biorbyt Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 209. Biorbyt Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 210. Biorbyt Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 211. Biorbyt Main Business
Table 212. Biorbyt Latest Developments
Table 213. Abbexa Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 214. Abbexa Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 215. Abbexa Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 216. Abbexa Main Business
Table 217. Abbexa Latest Developments
Table 218. AMSBIO Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 219. AMSBIO Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 220. AMSBIO Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 221. AMSBIO Main Business
Table 222. AMSBIO Latest Developments
Table 223. Tocris Bioscience Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 224. Tocris Bioscience Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 225. Tocris Bioscience Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 226. Tocris Bioscience Main Business
Table 227. Tocris Bioscience Latest Developments
Table 228. Hello Bio Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 229. Hello Bio Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 230. Hello Bio Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 231. Hello Bio Main Business
Table 232. Hello Bio Latest Developments
Table 233. Axon Medchem Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 234. Axon Medchem Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 235. Axon Medchem Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 236. Axon Medchem Main Business
Table 237. Axon Medchem Latest Developments
Table 238. Alomone Labs?IL? Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 239. Alomone Labs?IL? Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 240. Alomone Labs?IL? Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 241. Alomone Labs?IL? Main Business
Table 242. Alomone Labs?IL? Latest Developments
Table 243. FUJIFILM Wako Pure Chemical Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 244. FUJIFILM Wako Pure Chemical Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 245. FUJIFILM Wako Pure Chemical Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 246. FUJIFILM Wako Pure Chemical Main Business
Table 247. FUJIFILM Wako Pure Chemical Latest Developments
Table 248. Sumitomo Pharma Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 249. Sumitomo Pharma Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 250. Sumitomo Pharma Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 251. Sumitomo Pharma Main Business
Table 252. Sumitomo Pharma Latest Developments
Table 253. Boehringer Ingelheim Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 254. Boehringer Ingelheim Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 255. Boehringer Ingelheim Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 256. Boehringer Ingelheim Main Business
Table 257. Boehringer Ingelheim Latest Developments
Table 258. AstraZeneca Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 259. AstraZeneca Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 260. AstraZeneca Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 261. AstraZeneca Main Business
Table 262. AstraZeneca Latest Developments
Table 263. Denovo Biopharma Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 264. Denovo Biopharma Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 265. Denovo Biopharma Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 266. Denovo Biopharma Main Business
Table 267. Denovo Biopharma Latest Developments
Table 268. Addex Therapeutics Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 269. Addex Therapeutics Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 270. Addex Therapeutics Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 271. Addex Therapeutics Main Business
Table 272. Addex Therapeutics Latest Developments
Table 273. Noema Pharma Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 274. Noema Pharma Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 275. Noema Pharma Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 276. Noema Pharma Main Business
Table 277. Noema Pharma Latest Developments
Table 278. BOC Sciences Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 279. BOC Sciences Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 280. BOC Sciences Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 281. BOC Sciences Main Business
Table 282. BOC Sciences Latest Developments
Table 283. CUSABIO Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 284. CUSABIO Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 285. CUSABIO Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 286. CUSABIO Main Business
Table 287. CUSABIO Latest Developments
Table 288. HUABIO Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 289. HUABIO Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 290. HUABIO Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 291. HUABIO Main Business
Table 292. HUABIO Latest Developments
Table 293. Abbkine Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 294. Abbkine Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 295. Abbkine Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 296. Abbkine Main Business
Table 297. Abbkine Latest Developments
Table 298. FineTest Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 299. FineTest Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 300. FineTest Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 301. FineTest Main Business
Table 302. FineTest Latest Developments
Table 303. Bioss Antibodies Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 304. Bioss Antibodies Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 305. Bioss Antibodies Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 306. Bioss Antibodies Main Business
Table 307. Bioss Antibodies Latest Developments
Table 1. Metabotropic Glutamate Receptor 2 Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Metabotropic Glutamate Receptor 2 Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of LY-487379
Table 4. Major Players of JNJ-40411813
Table 5. Major Players of ADX71149
Table 6. Major Players of Others
Table 7. Global Metabotropic Glutamate Receptor 2 Sales by Type (2021-2026) & (K Pcs)
Table 8. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2021-2026)
Table 9. Global Metabotropic Glutamate Receptor 2 Revenue by Type (2021-2026) & ($ million)
Table 10. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2021-2026)
Table 11. Global Metabotropic Glutamate Receptor 2 Sale Price by Type (2021-2026) & (USD/Pcs)
Table 12. Major Players of Protein-based Reagents
Table 13. Major Players of Cell-based Products
Table 14. Major Players of Synthetic Chemical Products
Table 15. Global Metabotropic Glutamate Receptor 2 Sales by Biological Material Type (2021-2026) & (K Pcs)
Table 16. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Biological Material Type (2021-2026)
Table 17. Global Metabotropic Glutamate Receptor 2 Revenue by Biological Material Type (2021-2026) & ($ million)
Table 18. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Biological Material Type (2021-2026)
Table 19. Global Metabotropic Glutamate Receptor 2 Sale Price by Biological Material Type (2021-2026) & (USD/Pcs)
Table 20. Major Players of Positive Allosteric Modulators
Table 21. Major Players of Negative Allosteric Modulators
Table 22. Major Players of Non-modulating Detection Reagents
Table 23. Global Metabotropic Glutamate Receptor 2 Sales by Receptor Pharmacological Action (2021-2026) & (K Pcs)
Table 24. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Receptor Pharmacological Action (2021-2026)
Table 25. Global Metabotropic Glutamate Receptor 2 Revenue by Receptor Pharmacological Action (2021-2026) & ($ million)
Table 26. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Receptor Pharmacological Action (2021-2026)
Table 27. Global Metabotropic Glutamate Receptor 2 Sale Price by Receptor Pharmacological Action (2021-2026) & (USD/Pcs)
Table 28. Major Players of Polyclonal Antibodies
Table 29. Major Players of Hybridoma Monoclonal Antibodies
Table 30. Major Players of Recombinant Monoclonal Antibodies
Table 31. Global Metabotropic Glutamate Receptor 2 Sales by Antibody Generation Technology (2021-2026) & (K Pcs)
Table 32. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Antibody Generation Technology (2021-2026)
Table 33. Global Metabotropic Glutamate Receptor 2 Revenue by Antibody Generation Technology (2021-2026) & ($ million)
Table 34. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Antibody Generation Technology (2021-2026)
Table 35. Global Metabotropic Glutamate Receptor 2 Sale Price by Antibody Generation Technology (2021-2026) & (USD/Pcs)
Table 36. Global Metabotropic Glutamate Receptor 2 Sale by Application (2021-2026) & (K Pcs)
Table 37. Global Metabotropic Glutamate Receptor 2 Sale Market Share by Application (2021-2026)
Table 38. Global Metabotropic Glutamate Receptor 2 Revenue by Application (2021-2026) & ($ million)
Table 39. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Application (2021-2026)
Table 40. Global Metabotropic Glutamate Receptor 2 Sale Price by Application (2021-2026) & (USD/Pcs)
Table 41. Global Metabotropic Glutamate Receptor 2 Sales by Company (2021-2026) & (K Pcs)
Table 42. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Company (2021-2026)
Table 43. Global Metabotropic Glutamate Receptor 2 Revenue by Company (2021-2026) & ($ millions)
Table 44. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Company (2021-2026)
Table 45. Global Metabotropic Glutamate Receptor 2 Sale Price by Company (2021-2026) & (USD/Pcs)
Table 46. Key Manufacturers Metabotropic Glutamate Receptor 2 Producing Area Distribution and Sales Area
Table 47. Players Metabotropic Glutamate Receptor 2 Products Offered
Table 48. Metabotropic Glutamate Receptor 2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 49. New Products and Potential Entrants
Table 50. Market M&A Activity & Strategy
Table 51. Global Metabotropic Glutamate Receptor 2 Sales by Geographic Region (2021-2026) & (K Pcs)
Table 52. Global Metabotropic Glutamate Receptor 2 Sales Market Share Geographic Region (2021-2026)
Table 53. Global Metabotropic Glutamate Receptor 2 Revenue by Geographic Region (2021-2026) & ($ millions)
Table 54. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Geographic Region (2021-2026)
Table 55. Global Metabotropic Glutamate Receptor 2 Sales by Country/Region (2021-2026) & (K Pcs)
Table 56. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Country/Region (2021-2026)
Table 57. Global Metabotropic Glutamate Receptor 2 Revenue by Country/Region (2021-2026) & ($ millions)
Table 58. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Country/Region (2021-2026)
Table 59. Americas Metabotropic Glutamate Receptor 2 Sales by Country (2021-2026) & (K Pcs)
Table 60. Americas Metabotropic Glutamate Receptor 2 Sales Market Share by Country (2021-2026)
Table 61. Americas Metabotropic Glutamate Receptor 2 Revenue by Country (2021-2026) & ($ millions)
Table 62. Americas Metabotropic Glutamate Receptor 2 Sales by Type (2021-2026) & (K Pcs)
Table 63. Americas Metabotropic Glutamate Receptor 2 Sales by Application (2021-2026) & (K Pcs)
Table 64. APAC Metabotropic Glutamate Receptor 2 Sales by Region (2021-2026) & (K Pcs)
Table 65. APAC Metabotropic Glutamate Receptor 2 Sales Market Share by Region (2021-2026)
Table 66. APAC Metabotropic Glutamate Receptor 2 Revenue by Region (2021-2026) & ($ millions)
Table 67. APAC Metabotropic Glutamate Receptor 2 Sales by Type (2021-2026) & (K Pcs)
Table 68. APAC Metabotropic Glutamate Receptor 2 Sales by Application (2021-2026) & (K Pcs)
Table 69. Europe Metabotropic Glutamate Receptor 2 Sales by Country (2021-2026) & (K Pcs)
Table 70. Europe Metabotropic Glutamate Receptor 2 Revenue by Country (2021-2026) & ($ millions)
Table 71. Europe Metabotropic Glutamate Receptor 2 Sales by Type (2021-2026) & (K Pcs)
Table 72. Europe Metabotropic Glutamate Receptor 2 Sales by Application (2021-2026) & (K Pcs)
Table 73. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Country (2021-2026) & (K Pcs)
Table 74. Middle East & Africa Metabotropic Glutamate Receptor 2 Revenue Market Share by Country (2021-2026)
Table 75. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Type (2021-2026) & (K Pcs)
Table 76. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales by Application (2021-2026) & (K Pcs)
Table 77. Key Market Drivers & Growth Opportunities of Metabotropic Glutamate Receptor 2
Table 78. Key Market Challenges & Risks of Metabotropic Glutamate Receptor 2
Table 79. Key Industry Trends of Metabotropic Glutamate Receptor 2
Table 80. Metabotropic Glutamate Receptor 2 Raw Material
Table 81. Key Suppliers of Raw Materials
Table 82. Metabotropic Glutamate Receptor 2 Distributors List
Table 83. Metabotropic Glutamate Receptor 2 Customer List
Table 84. Global Metabotropic Glutamate Receptor 2 Sales Forecast by Region (2027-2032) & (K Pcs)
Table 85. Global Metabotropic Glutamate Receptor 2 Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Americas Metabotropic Glutamate Receptor 2 Sales Forecast by Country (2027-2032) & (K Pcs)
Table 87. Americas Metabotropic Glutamate Receptor 2 Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. APAC Metabotropic Glutamate Receptor 2 Sales Forecast by Region (2027-2032) & (K Pcs)
Table 89. APAC Metabotropic Glutamate Receptor 2 Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 90. Europe Metabotropic Glutamate Receptor 2 Sales Forecast by Country (2027-2032) & (K Pcs)
Table 91. Europe Metabotropic Glutamate Receptor 2 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 92. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales Forecast by Country (2027-2032) & (K Pcs)
Table 93. Middle East & Africa Metabotropic Glutamate Receptor 2 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 94. Global Metabotropic Glutamate Receptor 2 Sales Forecast by Type (2027-2032) & (K Pcs)
Table 95. Global Metabotropic Glutamate Receptor 2 Revenue Forecast by Type (2027-2032) & ($ millions)
Table 96. Global Metabotropic Glutamate Receptor 2 Sales Forecast by Application (2027-2032) & (K Pcs)
Table 97. Global Metabotropic Glutamate Receptor 2 Revenue Forecast by Application (2027-2032) & ($ millions)
Table 98. Thermo Fisher Scientific Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 99. Thermo Fisher Scientific Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 100. Thermo Fisher Scientific Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 101. Thermo Fisher Scientific Main Business
Table 102. Thermo Fisher Scientific Latest Developments
Table 103. Merck KGaA Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 104. Merck KGaA Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 105. Merck KGaA Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 106. Merck KGaA Main Business
Table 107. Merck KGaA Latest Developments
Table 108. Danaher Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 109. Danaher Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 110. Danaher Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 111. Danaher Main Business
Table 112. Danaher Latest Developments
Table 113. Bio-Techne Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 114. Bio-Techne Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 115. Bio-Techne Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 116. Bio-Techne Main Business
Table 117. Bio-Techne Latest Developments
Table 118. Cell Signaling Technology Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 119. Cell Signaling Technology Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 120. Cell Signaling Technology Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 121. Cell Signaling Technology Main Business
Table 122. Cell Signaling Technology Latest Developments
Table 123. Proteintech Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 124. Proteintech Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 125. Proteintech Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 126. Proteintech Main Business
Table 127. Proteintech Latest Developments
Table 128. OriGene Technologies Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 129. OriGene Technologies Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 130. OriGene Technologies Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 131. OriGene Technologies Main Business
Table 132. OriGene Technologies Latest Developments
Table 133. GeneTex Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 134. GeneTex Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 135. GeneTex Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 136. GeneTex Main Business
Table 137. GeneTex Latest Developments
Table 138. Santa Cruz Biotechnology Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 139. Santa Cruz Biotechnology Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 140. Santa Cruz Biotechnology Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 141. Santa Cruz Biotechnology Main Business
Table 142. Santa Cruz Biotechnology Latest Developments
Table 143. Cayman Chemical Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 144. Cayman Chemical Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 145. Cayman Chemical Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 146. Cayman Chemical Main Business
Table 147. Cayman Chemical Latest Developments
Table 148. MedChemExpress Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 149. MedChemExpress Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 150. MedChemExpress Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 151. MedChemExpress Main Business
Table 152. MedChemExpress Latest Developments
Table 153. Selleck Chemicals Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 154. Selleck Chemicals Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 155. Selleck Chemicals Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 156. Selleck Chemicals Main Business
Table 157. Selleck Chemicals Latest Developments
Table 158. TargetMol Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 159. TargetMol Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 160. TargetMol Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 161. TargetMol Main Business
Table 162. TargetMol Latest Developments
Table 163. ApexBio Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 164. ApexBio Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 165. ApexBio Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 166. ApexBio Main Business
Table 167. ApexBio Latest Developments
Table 168. GLPBIO Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 169. GLPBIO Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 170. GLPBIO Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 171. GLPBIO Main Business
Table 172. GLPBIO Latest Developments
Table 173. Adooq Bioscience Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 174. Adooq Bioscience Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 175. Adooq Bioscience Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 176. Adooq Bioscience Main Business
Table 177. Adooq Bioscience Latest Developments
Table 178. MedKoo Biosciences Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 179. MedKoo Biosciences Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 180. MedKoo Biosciences Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 181. MedKoo Biosciences Main Business
Table 182. MedKoo Biosciences Latest Developments
Table 183. MyBioSource Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 184. MyBioSource Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 185. MyBioSource Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 186. MyBioSource Main Business
Table 187. MyBioSource Latest Developments
Table 188. Aviva Systems Biology Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 189. Aviva Systems Biology Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 190. Aviva Systems Biology Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 191. Aviva Systems Biology Main Business
Table 192. Aviva Systems Biology Latest Developments
Table 193. Signalway Antibody Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 194. Signalway Antibody Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 195. Signalway Antibody Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 196. Signalway Antibody Main Business
Table 197. Signalway Antibody Latest Developments
Table 198. NSJ Bioreagents Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 199. NSJ Bioreagents Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 200. NSJ Bioreagents Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 201. NSJ Bioreagents Main Business
Table 202. NSJ Bioreagents Latest Developments
Table 203. Antibodies Incorporated Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 204. Antibodies Incorporated Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 205. Antibodies Incorporated Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 206. Antibodies Incorporated Main Business
Table 207. Antibodies Incorporated Latest Developments
Table 208. Biorbyt Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 209. Biorbyt Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 210. Biorbyt Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 211. Biorbyt Main Business
Table 212. Biorbyt Latest Developments
Table 213. Abbexa Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 214. Abbexa Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 215. Abbexa Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 216. Abbexa Main Business
Table 217. Abbexa Latest Developments
Table 218. AMSBIO Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 219. AMSBIO Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 220. AMSBIO Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 221. AMSBIO Main Business
Table 222. AMSBIO Latest Developments
Table 223. Tocris Bioscience Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 224. Tocris Bioscience Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 225. Tocris Bioscience Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 226. Tocris Bioscience Main Business
Table 227. Tocris Bioscience Latest Developments
Table 228. Hello Bio Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 229. Hello Bio Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 230. Hello Bio Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 231. Hello Bio Main Business
Table 232. Hello Bio Latest Developments
Table 233. Axon Medchem Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 234. Axon Medchem Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 235. Axon Medchem Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 236. Axon Medchem Main Business
Table 237. Axon Medchem Latest Developments
Table 238. Alomone Labs?IL? Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 239. Alomone Labs?IL? Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 240. Alomone Labs?IL? Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 241. Alomone Labs?IL? Main Business
Table 242. Alomone Labs?IL? Latest Developments
Table 243. FUJIFILM Wako Pure Chemical Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 244. FUJIFILM Wako Pure Chemical Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 245. FUJIFILM Wako Pure Chemical Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 246. FUJIFILM Wako Pure Chemical Main Business
Table 247. FUJIFILM Wako Pure Chemical Latest Developments
Table 248. Sumitomo Pharma Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 249. Sumitomo Pharma Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 250. Sumitomo Pharma Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 251. Sumitomo Pharma Main Business
Table 252. Sumitomo Pharma Latest Developments
Table 253. Boehringer Ingelheim Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 254. Boehringer Ingelheim Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 255. Boehringer Ingelheim Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 256. Boehringer Ingelheim Main Business
Table 257. Boehringer Ingelheim Latest Developments
Table 258. AstraZeneca Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 259. AstraZeneca Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 260. AstraZeneca Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 261. AstraZeneca Main Business
Table 262. AstraZeneca Latest Developments
Table 263. Denovo Biopharma Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 264. Denovo Biopharma Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 265. Denovo Biopharma Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 266. Denovo Biopharma Main Business
Table 267. Denovo Biopharma Latest Developments
Table 268. Addex Therapeutics Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 269. Addex Therapeutics Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 270. Addex Therapeutics Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 271. Addex Therapeutics Main Business
Table 272. Addex Therapeutics Latest Developments
Table 273. Noema Pharma Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 274. Noema Pharma Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 275. Noema Pharma Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 276. Noema Pharma Main Business
Table 277. Noema Pharma Latest Developments
Table 278. BOC Sciences Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 279. BOC Sciences Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 280. BOC Sciences Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 281. BOC Sciences Main Business
Table 282. BOC Sciences Latest Developments
Table 283. CUSABIO Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 284. CUSABIO Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 285. CUSABIO Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 286. CUSABIO Main Business
Table 287. CUSABIO Latest Developments
Table 288. HUABIO Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 289. HUABIO Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 290. HUABIO Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 291. HUABIO Main Business
Table 292. HUABIO Latest Developments
Table 293. Abbkine Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 294. Abbkine Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 295. Abbkine Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 296. Abbkine Main Business
Table 297. Abbkine Latest Developments
Table 298. FineTest Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 299. FineTest Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 300. FineTest Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 301. FineTest Main Business
Table 302. FineTest Latest Developments
Table 303. Bioss Antibodies Basic Information, Metabotropic Glutamate Receptor 2 Manufacturing Base, Sales Area and Its Competitors
Table 304. Bioss Antibodies Metabotropic Glutamate Receptor 2 Product Portfolios and Specifications
Table 305. Bioss Antibodies Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2021-2026)
Table 306. Bioss Antibodies Main Business
Table 307. Bioss Antibodies Latest Developments
LIST OF FIGURES
Figure 1. Picture of Metabotropic Glutamate Receptor 2
Figure 2. Metabotropic Glutamate Receptor 2 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Metabotropic Glutamate Receptor 2 Sales Growth Rate 2021-2032 (K Pcs)
Figure 7. Global Metabotropic Glutamate Receptor 2 Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Metabotropic Glutamate Receptor 2 Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Metabotropic Glutamate Receptor 2 Sales Market Share by Country/Region (2025)
Figure 10. Metabotropic Glutamate Receptor 2 Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of LY-487379
Figure 12. Product Picture of JNJ-40411813
Figure 13. Product Picture of ADX71149
Figure 14. Product Picture of Others
Figure 15. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type in 2026
Figure 16. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Protein-based Reagents
Figure 18. Product Picture of Cell-based Products
Figure 19. Product Picture of Synthetic Chemical Products
Figure 20. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Biological Material Type in 2026
Figure 21. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Biological Material Type (2021-2026)
Figure 22. Product Picture of Positive Allosteric Modulators
Figure 23. Product Picture of Negative Allosteric Modulators
Figure 24. Product Picture of Non-modulating Detection Reagents
Figure 25. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Receptor Pharmacological Action in 2026
Figure 26. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Receptor Pharmacological Action (2021-2026)
Figure 27. Product Picture of Polyclonal Antibodies
Figure 28. Product Picture of Hybridoma Monoclonal Antibodies
Figure 29. Product Picture of Recombinant Monoclonal Antibodies
Figure 30. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Antibody Generation Technology in 2026
Figure 31. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Antibody Generation Technology (2021-2026)
Figure 32. Metabotropic Glutamate Receptor 2 Consumed in Anxiety Disorders
Figure 33. Global Metabotropic Glutamate Receptor 2 Market: Anxiety Disorders (2021-2026) & (K Pcs)
Figure 34. Metabotropic Glutamate Receptor 2 Consumed in Depression
Figure 35. Global Metabotropic Glutamate Receptor 2 Market: Depression (2021-2026) & (K Pcs)
Figure 36. Metabotropic Glutamate Receptor 2 Consumed in Schizophrenia
Figure 37. Global Metabotropic Glutamate Receptor 2 Market: Schizophrenia (2021-2026) & (K Pcs)
Figure 38. Metabotropic Glutamate Receptor 2 Consumed in Chronic Pain
Figure 39. Global Metabotropic Glutamate Receptor 2 Market: Chronic Pain (2021-2026) & (K Pcs)
Figure 40. Metabotropic Glutamate Receptor 2 Consumed in Others
Figure 41. Global Metabotropic Glutamate Receptor 2 Market: Others (2021-2026) & (K Pcs)
Figure 42. Global Metabotropic Glutamate Receptor 2 Sale Market Share by Application (2025)
Figure 43. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Application in 2025
Figure 44. Metabotropic Glutamate Receptor 2 Sales by Company in 2025 (K Pcs)
Figure 45. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Company in 2025
Figure 46. Metabotropic Glutamate Receptor 2 Revenue by Company in 2025 ($ millions)
Figure 47. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Company in 2025
Figure 48. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Geographic Region (2021-2026)
Figure 49. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Geographic Region in 2025
Figure 50. Americas Metabotropic Glutamate Receptor 2 Sales 2021-2026 (K Pcs)
Figure 51. Americas Metabotropic Glutamat
Figure 1. Picture of Metabotropic Glutamate Receptor 2
Figure 2. Metabotropic Glutamate Receptor 2 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Metabotropic Glutamate Receptor 2 Sales Growth Rate 2021-2032 (K Pcs)
Figure 7. Global Metabotropic Glutamate Receptor 2 Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Metabotropic Glutamate Receptor 2 Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Metabotropic Glutamate Receptor 2 Sales Market Share by Country/Region (2025)
Figure 10. Metabotropic Glutamate Receptor 2 Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of LY-487379
Figure 12. Product Picture of JNJ-40411813
Figure 13. Product Picture of ADX71149
Figure 14. Product Picture of Others
Figure 15. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type in 2026
Figure 16. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Protein-based Reagents
Figure 18. Product Picture of Cell-based Products
Figure 19. Product Picture of Synthetic Chemical Products
Figure 20. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Biological Material Type in 2026
Figure 21. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Biological Material Type (2021-2026)
Figure 22. Product Picture of Positive Allosteric Modulators
Figure 23. Product Picture of Negative Allosteric Modulators
Figure 24. Product Picture of Non-modulating Detection Reagents
Figure 25. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Receptor Pharmacological Action in 2026
Figure 26. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Receptor Pharmacological Action (2021-2026)
Figure 27. Product Picture of Polyclonal Antibodies
Figure 28. Product Picture of Hybridoma Monoclonal Antibodies
Figure 29. Product Picture of Recombinant Monoclonal Antibodies
Figure 30. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Antibody Generation Technology in 2026
Figure 31. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Antibody Generation Technology (2021-2026)
Figure 32. Metabotropic Glutamate Receptor 2 Consumed in Anxiety Disorders
Figure 33. Global Metabotropic Glutamate Receptor 2 Market: Anxiety Disorders (2021-2026) & (K Pcs)
Figure 34. Metabotropic Glutamate Receptor 2 Consumed in Depression
Figure 35. Global Metabotropic Glutamate Receptor 2 Market: Depression (2021-2026) & (K Pcs)
Figure 36. Metabotropic Glutamate Receptor 2 Consumed in Schizophrenia
Figure 37. Global Metabotropic Glutamate Receptor 2 Market: Schizophrenia (2021-2026) & (K Pcs)
Figure 38. Metabotropic Glutamate Receptor 2 Consumed in Chronic Pain
Figure 39. Global Metabotropic Glutamate Receptor 2 Market: Chronic Pain (2021-2026) & (K Pcs)
Figure 40. Metabotropic Glutamate Receptor 2 Consumed in Others
Figure 41. Global Metabotropic Glutamate Receptor 2 Market: Others (2021-2026) & (K Pcs)
Figure 42. Global Metabotropic Glutamate Receptor 2 Sale Market Share by Application (2025)
Figure 43. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Application in 2025
Figure 44. Metabotropic Glutamate Receptor 2 Sales by Company in 2025 (K Pcs)
Figure 45. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Company in 2025
Figure 46. Metabotropic Glutamate Receptor 2 Revenue by Company in 2025 ($ millions)
Figure 47. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Company in 2025
Figure 48. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Geographic Region (2021-2026)
Figure 49. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Geographic Region in 2025
Figure 50. Americas Metabotropic Glutamate Receptor 2 Sales 2021-2026 (K Pcs)
Figure 51. Americas Metabotropic Glutamat
